| __timestamp | Biogen Inc. | Regeneron Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 1893422000 | 1271353000 |
| Thursday, January 1, 2015 | 2012800000 | 1620577000 |
| Friday, January 1, 2016 | 1973300000 | 2052295000 |
| Sunday, January 1, 2017 | 2253600000 | 2075142000 |
| Monday, January 1, 2018 | 2597200000 | 2186100000 |
| Tuesday, January 1, 2019 | 2280600000 | 3036600000 |
| Wednesday, January 1, 2020 | 3990900000 | 2735000000 |
| Friday, January 1, 2021 | 2501200000 | 2908100000 |
| Saturday, January 1, 2022 | 2231100000 | 3592500000 |
| Sunday, January 1, 2023 | 2702600000 | 4439000000 |
| Monday, January 1, 2024 | 2041800000 | 5132000000 |
Igniting the spark of knowledge
In the competitive world of pharmaceuticals, innovation is key to staying ahead. Over the past decade, Regeneron Pharmaceuticals, Inc. and Biogen Inc. have demonstrated their commitment to research and development (R&D) with significant investments. From 2014 to 2023, Regeneron increased its R&D spending by approximately 250%, peaking at $4.4 billion in 2023. In contrast, Biogen's R&D expenditure grew by about 43% over the same period, reaching $2.7 billion in 2023.
While both companies have shown dedication to innovation, Regeneron's aggressive investment strategy has positioned it as a leader in the field. This trend highlights the company's focus on pioneering new treatments and therapies. As the pharmaceutical landscape evolves, these investments will likely play a crucial role in shaping the future of healthcare.
R&D Spending Showdown: Pfizer Inc. vs Biogen Inc.
Research and Development Investment: Regeneron Pharmaceuticals, Inc. vs Pharming Group N.V.
Analyzing R&D Budgets: Regeneron Pharmaceuticals, Inc. vs Ultragenyx Pharmaceutical Inc.
Analyzing R&D Budgets: Regeneron Pharmaceuticals, Inc. vs Veracyte, Inc.
Regeneron Pharmaceuticals, Inc. vs Agios Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Regeneron Pharmaceuticals, Inc. and MannKind Corporation
Who Prioritizes Innovation? R&D Spending Compared for Regeneron Pharmaceuticals, Inc. and Supernus Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Biogen Inc. and BioMarin Pharmaceutical Inc.
Comparing Innovation Spending: Biogen Inc. and Opthea Limited
Comparing Innovation Spending: Biogen Inc. and Pharming Group N.V.
Who Prioritizes Innovation? R&D Spending Compared for Biogen Inc. and Protagonist Therapeutics, Inc.
Research and Development Investment: Biogen Inc. vs MiMedx Group, Inc.